9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...

9/8/2025Avadel Partners with XWPharma to Advance Valiloxybate for Sleep Disord...

9/5/2025Yangtze River's Fexuprazan Gains Chinese Approval

9/5/20253SBio Secures IND Nod for Dual-Target CAR-T Therapy SA102

9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...

9/4/2025Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...

9/3/2025Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...

9/2/2025Nine First-in-Class Drugs Receive Initial Clinical Approval in China

9/2/2025China Approved Seven New Drugs in August

9/1/2025BioNTech Launches Phase 1/2 Trial of BNT327 and BNT3212 in Advanced Tu...

9/1/2025Hongcheng Launches Phase II Trial for PD-1/CTLA-4/VEGF TsAb in Advance...

9/1/2025Novel iPSC-Derived Neural Cell Therapy Shows Promise in SCI Treatment

9/1/2025Hengrui Seeks NMPA Approval for New Dual-Receptor Obesity Drug HRS9531

8/30/2025CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib

8/29/2025D3 Bio's D3S-001 Receives FDA Breakthru Therapy and Orphan Drug Design...

8/29/2025Boehringer's Zongertinib Gains Conditional Approval in China

8/29/2025Hengrui's SHR2554 Receives Conditional NMPA Approval

8/29/2025Akeso Advances First Bispecific ADC Into Clinical Stage With First Pat...

8/26/2025Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...

8/26/2025Arnatar Debuts with FDA Designations for Alagille Syndrome Candidate A...

8/26/2025Akeso's Dual Phase III Victories Highlight Expansion of Non-Oncology T...

8/26/2025Simcere's Daridorexant Phase III Data Published and Approved in China

8/26/2025Pregene Secures Orphan Drug Status for Innovative Dual-Target CAR-T Th...

8/26/2025CorrectSequence's CS-101: A Breakthru Base-Editing Therapy Cures First...

8/26/2025Centergene's SJ02 Approved for Marketing, Advancing Assisted Reproduct...

8/25/2025HemaCell Receives FDA IND Approval for Megakaryocyte Therapy

8/25/2025Vivace Therapeutics Secures FDA Orphan Drug Designation for VT3989 in ...

8/22/2025NMPA Approves AZ/Daiichi Sankyo's Datopotamab Deruxtecan

8/22/2025Innovent Advances Immuno-Oncology with IBI3026 CTA Acceptance

8/22/2025Xuanzhu's Dexitinib Gains Approval for ALK-Positive Advanced NSCLC in ...

Page:11/22 Total number of articles:647: [First][<<] [9] [10] [11] [12] [13] [>>] [End]